Biodexa Pharmaceuticals PLC DRC (BDRX)

NASDAQ

Currency in USD

BDRX Pro Research

0.612

-0.043(-6.50%)

Closed·20:59:59

After Hours

0.630+0.018(+3.01%)

·22:38:46

Fair Value

Unlock Value

Day's Range

0.601

0.690

52 wk Range

0.601

19.300

BDRX Income Statement

Featured here, the Income Statement (earnings report) for Biodexa Pharmaceuticals PLC DRC, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually). - Test -{{UPSIDE_OR_DOWNSIDE}} - {{DIVIDEND_YIELD}} - {{CURRENT_YEAR}}

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

0.58

0.7

0.38

Total Revenues Growth

aa.aa

+68.51%

+20.93%

-45.49%

Cost Of Revenues

aa.aa

4.65

5.11

4.07

5.44

Gross Profit

aa.aa

-4.08

-4.41

-3.69

-5.44

Gross Profit Growth

aa.aa

+28.8%

-8.24%

+16.46%

-47.5%

Gross Profit Margin %

aa.aa

-705.19%

-631.19%

-967.45%

Other Operating Expenses, Total

aa.aa

2.92

4.52

3.02

3.76

8.65

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-40.92%	+54.69%	-33.23%	+24.65%	+129.8%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	3.96
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	2.95	4.54	3.03	3.79	4.84
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-0.02	-0.02	-0.01	-0.03	-0.15

Operating Income

aa.aa

-7

-8.93

-6.7

-9.2

-8.65

Operating Income Growth

aa.aa

+34.42%

-27.64%

+24.94%

-37.22%

+6.02%

EBIT Margin %

aa.aa

-1,210.73%

-1,277.83%

-1,759.58%

Net Interest Expenses

aa.aa

-0.04

-0.02

0.04

-0.23

Net Interest Expenses Growth

aa.aa

-33.33%

+45.45%

+275%

-95.24%

-11,550%

Interest Expense, Total

aa.aa

-0.04

-0.05

-0.04

-0.17

-0.23

Interest And Investment Income

aa.aa

0.03

0.08

0.17

Other Non Operating Expenses, Total

aa.aa

0.94

0.47

0.49

3.22

2.39

EBT, Excl. Unusual Items

aa.aa

-6.11

-8.49

-6.18

-5.98

-6.49

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

-1.31

EBT, Incl. Unusual Items

aa.aa

-6.11

-8.49

-7.49

-5.98

-6.49

EBT, Incl. Unusual Items Growth

aa.aa

+73.98%

-39.01%

+11.82%

+20.12%

-8.53%

EBT, Incl. Unusual Items Margin

aa.aa

-1,056.4%

-1,214.31%

-1,964.57%

Income Tax Expense

aa.aa

-0.65

-0.83

-0.41

-0.25

-0.11

Net Income to Company

aa.aa

-5.46

-7.66

-7.08

-5.73

-6.38

Minority Interest

aa.aa

Net Income

aa.aa

-5.46

-7.66

-7.08

-5.73

-6.38

Net Income Growth

aa.aa

+75.39%

-40.22%

+7.54%

+19.07%

-11.43%

Net Income Margin %

aa.aa

-944.64%

-1,095.28%

-1,858.01%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-5.46

-7.66

-7.08

-5.73

-6.38

Basic EPS - Continuing Operations

aa.aa

-115.67

-10

Basic EPS - Continuing Operations Growth

aa.aa

+91.35%

Diluted EPS - Continuing Operations

aa.aa

-115.67

-10

Diluted EPS - Continuing Operations Growth

aa.aa

+91.35%

Basic Weighted Average Shares Outstanding

aa.aa

0.05

0.64

Diluted Weighted Average Shares Outstanding

aa.aa

0.05

0.64

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

-6.79

-8.76

-6.56

-9.08

-8.59

EBITDA Growth

aa.aa

+29.12%

-29.08%

+25.09%

-38.42%

+5.4%

EBITDA Margin %

aa.aa

-1,173.88%

-1,252.93%

-1,722.05%

EBIT

aa.aa

-7

-8.93

-6.7

-9.2

-8.65

* In Millions of GBP (except for per share items)

FAQ

What was Biodexa Pharmaceuticals DRC’s net income for the year?

For the full year, Biodexa Pharmaceuticals DRC reported net income of -6.384 million GBP.

How much net income did Biodexa Pharmaceuticals DRC post in the last quarter?

In the most recent quarter, Biodexa Pharmaceuticals DRC (BDRX) posted net income of -3.806 million GBP.

How much gross profit did Biodexa Pharmaceuticals DRC generate last quarter?

Biodexa Pharmaceuticals DRC recorded gross profit of -1.665 million GBP in its latest quarterly report.

What was Biodexa Pharmaceuticals DRC’s annual operating income?

For the full year, Biodexa Pharmaceuticals DRC (BDRX) reported operating income of -8.645 million GBP.

What was Biodexa Pharmaceuticals DRC’s operating income last quarter?

Quarterly operating income was -4.016 million GBP.

What was Biodexa Pharmaceuticals DRC’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at -3.945 million GBP.

What was the quarter-over-quarter change in EBITDA for Biodexa Pharmaceuticals DRC?

EBITDA changed by 19.931% million GBP compared to the last quarter.

What was the quarter-over-quarter change in gross profit for Biodexa Pharmaceuticals DRC?

In the latest quarter, gross profit changed by 48.738% million GBP from the previous quarter.

NSE 30

7,266.42

-16.54

-0.23%

NSE All Share

200,484.44

-428.63

-0.21%

US 30

45,246.00

+29.3

+0.06%

US 500

6,344.30

+0.5

+0.01%

FTSE 100

10,127.96

+160.61

+1.61%

DAX

22,562.88

+262.13

+1.18%

South Africa Top 40

104,653.03

+714.50

+0.69%

Market Movers

Name	Last	Chg. %	Vol.
Access Holdings	26.00	0.00%	86.64M
First HoldCo	51.00	+0.99%	84.56M
Zenith Bank	100.05	-2.86%	26.13M
Lafarge Africa	216.70	-3.26%	8.46M
MTN Nigeria	718.00	0.00%	2.88M
Aradel Holdings	1,260.00	0.00%	1.24M
Nestle Nigeria	3,395.00	0.00%	736.28K

Name	Last	Chg. %	Vol.
Secure Electronic Tech	1.17	-10.00%	31.12M
Maybaker	38.000	-9.42%	1.42M
Legend Internet	6.85	-8.67%	4.56M
Cutix	3.210	-8.29%	5.28M
Fortis Global Insurance	1.27	-7.97%	8.66M
Consolidated Hallmark	4.75	-6.13%	1.91M
Afriprud	14.60	-5.19%	1.14M

Trending Stocks

Name	Last	Chg. %	Vol.
MTN Nigeria	718.00	0.00%	2.88M
Zenith Bank	100.05	-2.86%	26.13M
Fidson	100.000	+5.43%	791.78K
Access Holdings	26.00	0.00%	86.64M
CWG	22.500	+2.27%	1.87M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaa Aaaa Aaaa Aaaa	39.000	+30.71%	50.977
Aaaa Aa	423.20	+27.75%	540.64
Aaaaaaa	810.00	+25.31%	1,015.01
Aaaaaaaaaa Aaaa	21.500	+25.13%	26.903
Aaaaaaaaaa	99.00	+20.85%	119.64
A Aaaaaa A	64.60	+19.33%	77.09
Aa Aaa Aaaaaaaaaaa	46.00	+19.22%	54.84

Name	Last	Upside	Fair Value
Aaaa Aaaa Aaaa Aaaa	39.000	+30.71%	50.977
Aaaa Aa	423.20	+27.75%	540.64
Aaaaaaa	810.00	+25.31%	1,015.01
Aaaaaaaaaa Aaaa	21.500	+25.13%	26.903
Aaaaaaaaaa	99.00	+20.85%	119.64
A Aaaaaa A	64.60	+19.33%	77.09
Aa Aaa Aaaaaaaaaaa	46.00	+19.22%	54.84

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Name	Last	Chg. %	Vol.
Austin Laz	4.41	+9.98%	884.93K
Transexpr	2.84	+9.65%	600.10K
Initiates	21.70	+9.60%	1.60M
Learn Africa	9.300	+9.41%	296.07K
Daarcomm	1.98	+9.39%	2.63M
McNichols	8.08	+8.89%	4.04M
Nahco	189.900	+8.83%	2.15M

Popular Searches

Please try another search

Biodexa Pharmaceuticals PLC DRC (BDRX)

BDRX Income Statement

FAQ

What was Biodexa Pharmaceuticals DRC’s net income for the year?

How much net income did Biodexa Pharmaceuticals DRC post in the last quarter?

How much gross profit did Biodexa Pharmaceuticals DRC generate last quarter?

What was Biodexa Pharmaceuticals DRC’s annual operating income?

What was Biodexa Pharmaceuticals DRC’s operating income last quarter?

What was Biodexa Pharmaceuticals DRC’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Biodexa Pharmaceuticals DRC?

What was the quarter-over-quarter change in gross profit for Biodexa Pharmaceuticals DRC?

Trending Stocks